Percutaneous left atrial appendage (LAA) closure is effective for stroke prevention in patients with atrial fibrillation and contraindication to anticoagulant therapy [(1)][1], providing a permanent protection from thromboembolism without lifelong anticoagulation. To date, no experimental, in vivo